Neutral third party versus treating institution for evaluating quality of life after radical cystectomy
- PMID: 15245813
- DOI: 10.1016/j.eururo.2004.04.010
Neutral third party versus treating institution for evaluating quality of life after radical cystectomy
Abstract
Objective: To evaluate the possible impact of a neutral third party on the patients' responses to health-related quality of life (HRQL) instruments.
Methods: 119 patients operated at the Department of Urology in Lund with radical cystectomy and continent urinary tract reconstruction (continent cutaneous diversion or orthotopic bladder substitution) for locally advanced bladder cancer were included in the study. They were randomly divided in two groups, similar with regard to gender, age, length of follow-up, and type of reconstruction. The EORTC instruments QLQ-C30 and QLQ-BLM30 were sent to the patients. One group; "Lund patients", received the instruments from the Department of Urology in Lund, while the other group; "Stockholm patients", received the instruments from a neutral third party, i.e. "The Project Health and Well-Being" at the Karolinska Institutet in Stockholm.
Results: Response rates were high in both groups, 59 out of 60 among Lund patients and 57 out of 59 among Stockholm patients. There were statistically significantly more bowel problems reported in the Stockholm patients than in the Lund patients (p<0.05) in the QLQ-C30 instrument. Regarding type of reconstruction, the Stockholm patients with continent cutaneous diversion scored higher for constipation than the Lund patients (p<0.05), and the Stockholm patients with bladder substitution scored lower for emotional functioning and higher for dyspnoea and economical problems than the Lund patients (p<0.05. There were no statistically significant differences between the Lund patients and the Stockholm patients in the QLQ-BLM30 instrument.
Conclusion: Though few factors differed between the two groups, the results may indicate that different results are obtained when a study is totally administered and analyzed by a neutral third party as compared with the surgeon or his or her institution. Larger studies are needed to further test this hypothesis.
Similar articles
-
Morbidity and quality of life in elderly patients receiving ileal conduit or orthotopic neobladder after radical cystectomy for invasive bladder cancer.Urology. 2008 May;71(5):919-23. doi: 10.1016/j.urology.2007.11.125. Epub 2008 Mar 20. Urology. 2008. PMID: 18355900
-
Continent cutaneous urinary diversion is still a valid alternative after cystectomy for bladder carcinoma.Scand J Urol Nephrol. 2005;39(6):468-73. doi: 10.1080/00365590500191001. Scand J Urol Nephrol. 2005. PMID: 16303722
-
Health related quality of life after radical cystectomy: comparison of ileal conduit to continent orthotopic neobladder.Eur J Surg Oncol. 2009 Aug;35(8):858-64. doi: 10.1016/j.ejso.2008.08.002. Epub 2008 Sep 27. Eur J Surg Oncol. 2009. PMID: 18824319
-
Quality of life after cystectomy and urinary diversion: an evidence based analysis.J Urol. 2005 Nov;174(5):1729-36. doi: 10.1097/01.ju.0000176463.40530.05. J Urol. 2005. PMID: 16217273 Review.
-
Current perioperative management of radical cystectomy with intestinal urinary reconstruction for muscle-invasive bladder cancer and reduction of the incidence of postoperative ileus.Surg Oncol. 2008 Jul;17(1):41-8. doi: 10.1016/j.suronc.2007.09.003. Epub 2007 Oct 24. Surg Oncol. 2008. PMID: 17962014 Review.
Cited by
-
Intrusive thoughts and quality of life among men with prostate cancer before and three months after surgery.Health Qual Life Outcomes. 2013 Sep 11;11:154. doi: 10.1186/1477-7525-11-154. Health Qual Life Outcomes. 2013. PMID: 24025241 Free PMC article.
-
Identifying radiation-induced survivorship syndromes affecting bowel health in a cohort of gynecological cancer survivors.PLoS One. 2017 Feb 3;12(2):e0171461. doi: 10.1371/journal.pone.0171461. eCollection 2017. PLoS One. 2017. PMID: 28158314 Free PMC article.
-
Thinking about one's own death after prostate-cancer diagnosis.Support Care Cancer. 2018 May;26(5):1665-1673. doi: 10.1007/s00520-017-3986-z. Epub 2017 Dec 9. Support Care Cancer. 2018. PMID: 29224177
-
Agreement between patient reported outcomes and clinical reports after radical prostatectomy - a prospective longitudinal study.BMC Urol. 2019 May 8;19(1):35. doi: 10.1186/s12894-019-0467-3. BMC Urol. 2019. PMID: 31068176 Free PMC article. Clinical Trial.
-
Morbidity and Quality of Life in Bladder Cancer Patients following Cystectomy and Urinary Diversion: A Single-Institution Comparison of Ileal Conduit versus Orthotopic Neobladder.ISRN Urol. 2012;2012:342796. doi: 10.5402/2012/342796. Epub 2012 Feb 6. ISRN Urol. 2012. PMID: 22523713 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources